Autologous Transplantation for Multiple Myeloma: A Research Study of Multiple Myeloma Using Chemotherapy Plus Growth Factor Primed Peripheral Blood Stem Cells Followed by Autologous Transplantation and Post-Transplant Immunotherapy.

Trial Profile

Autologous Transplantation for Multiple Myeloma: A Research Study of Multiple Myeloma Using Chemotherapy Plus Growth Factor Primed Peripheral Blood Stem Cells Followed by Autologous Transplantation and Post-Transplant Immunotherapy.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2012

At a glance

  • Drugs Filgrastim (Primary) ; Filgrastim (Primary) ; Carmustine; Cyclophosphamide; Dexamethasone; Etoposide; Interferon alpha; Mitoxantrone; Sargramostim; Sargramostim
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top